Literature DB >> 3840628

Adjuvant chemotherapy for operable breast cancer with positive axillary nodes: a comparison of CMFVP versus L-PAM.

S E Rivkin, H Glucksberg, M Foulkes, C K Osborne, W Tranum, N Gad-el-Mawla, J Constanzi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3840628     DOI： 10.1007/bf01655186

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  13 in total

1.  A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES.

Authors:  E A GEHAN
Journal:  Biometrika       Date:  1965-06       Impact factor: 2.445

Review 2.  Rationale for adjuvant chemotherapy.

Authors:  F M Schabel
Journal:  Cancer       Date:  1977-06       Impact factor: 6.860

3.  Current status of estrogen receptors in human breast cancer.

Authors:  W L McGuire
Journal:  Cancer       Date:  1975-08       Impact factor: 6.860

4.  Invasive carcinoma of the breast: prognostic significance of tumor size and involved axillary lymph nodes.

Authors:  C C Say; W L Donegan
Journal:  Cancer       Date:  1974-08       Impact factor: 6.860

5.  Surgical adjuvant therapy for breast cancer.

Authors:  B Fisher
Journal:  Cancer       Date:  1972-12       Impact factor: 6.860

6.  Cancer of the breast: size of neoplasm and prognosis.

Authors:  B Fisher; N H Slack; I D Bross
Journal:  Cancer       Date:  1969-11       Impact factor: 6.860

7.  1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings.

Authors:  B Fisher; P Carbone; S G Economou; R Frelick; A Glass; H Lerner; C Redmond; M Zelen; P Band; D L Katrych; N Wolmark; E R Fisher
Journal:  N Engl J Med       Date:  1975-01-16       Impact factor: 91.245

8.  Radical mastectomy versus radical mastectomy plus internal mammary dissection. Five-year results of an international cooperative study.

Authors:  J Lacour; P Bucalossi; E Cacers; G Jacobelli; T Koszarowski; M Le; C Rumeau-Rouquette; U Veronesi
Journal:  Cancer       Date:  1976-01       Impact factor: 6.860

9.  Combination chemotherapy (CMFVP) versus L-phenylalanine mustard (L-PAM) for operable breast cancer with positive axillary nodes: a Southwest Oncology Group Study.

Authors:  H Glucksberg; S E Rivkin; S Rasmussen; B Tranum; N Gad-el-Mawla; J Costanzi; B Hoogstraten; J Athens; T Maloney; J McCracken; C Vaughn
Journal:  Cancer       Date:  1982-08-01       Impact factor: 6.860

10.  Ten year follow-up results of patients with carcinoma of the breast in a co-operative clinical trial evaluating surgical adjuvant chemotherapy.

Authors:  B Fisher; N Slack; D Katrych; N Wolmark
Journal:  Surg Gynecol Obstet       Date:  1975-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.